▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2858 by analyst upside · 2026-11-13
ARGX
argenx SE
Healthcare · Market Cap $62B · P/E 34.0x
ANALYST PRICE TARGET
+16.9%
implied upside to consensus target
Current Price $981.33
Consensus Target $1147.35
Bull Target $1353.0
Bear Target $861.0
Analysts Covering 23
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
13
Hold
3
Sell
0
52-Week Low $661.85
52-Week High $1072.75
YTD Return +16.8%
FUNDAMENTALS
Market Cap $62B
P/E Ratio (TTM) 34.0x
Forward P/E 29.5x
EPS (TTM) $28.87
PEG Ratio 1.31
Dividend Yield N/A
Revenue (TTM) $5.9B
Profit Margin 31.7%
52-WEEK RANGE
52-Week Low $661.85
52-Week High $1072.75
Current Price $981.33
Bear Target $861.0
Bull Target $1353.0
● Now $981.33 ● Target $1147.35
TRADING DATA
Avg Volume 364K
YTD Return +16.8%
Analyst Count 23
Consensus Buy
Upside to Target +16.9%
Last Updated 2026-11-13

ANALYST SUMMARY

argenx SE (ARGX) is currently trading at $981.33 with a Wall Street consensus price target of $1147.35, implying potential upside of 16.9% over the next 12 months. 23 analysts currently cover ARGX, with a consensus rating of Buy - 87% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1353.0, while the most cautious has a target of $861.0.

ARGX operates in the Healthcare sector with a market capitalisation of $62B. The stock is up 16.8% year-to-date and is currently trading near the upper end of its 52-week range of $661.85 – $1072.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CAH +6.0%
Cardinal Health, Inc.
$64B · P/E 36.0x · Buy
BDX +4.8%
Becton, Dickinson and Company
$59B · P/E 42.6x · Buy
HUM +10.5%
Humana Inc.
$53B · P/E 43.3x · Buy
A +5.2%
Agilent Technologies, Inc.
$49B · P/E 34.1x · Buy
VEEV +7.9%
Veeva Systems Inc.
$49B · P/E 49.6x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ARGX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup - Reiterated
Buy → Buy 2026-10-27 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-10-23 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-10-23 62% win rate (8 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-10-23 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-10-23 Building track record
Baird - Reiterated
Neutral → Neutral 2026-10-23 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-10-20 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-10-14 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
66
out of 100
Coverage depth
24/30
Consensus clarity
20/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →